Pharmaceutical Research and Manufacturers of America President and CEO Billy Tauzin will end his leadership of the powerful trade and lobbying association for drugmakers on June 30, according to a written statement from the group. Tauzin, 66, has led the organization for more than five years. No specific reason was given for the planned departure, but Tauzin is expected to continue as a consultant to PhRMA. In the statement, Tauzin said he thought it was time to move on and hand the reins to new leadership. Tauzin, a former congressman who represented a Louisiana district from 1980 to 2005, brought Capitol Hill relationships with him when he took over leadership of the organization in 2005. He is also a cancer survivor. PhRMA said in its statement that it has already launched a search for Tauzin's replacement. Tauzin ranked No. 39 on Modern Healthcare's annual list of the 100 Most Powerful People in Healthcare in 2009.
Late News: Tauzin stepping down as PhRMA president, CEO
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.